USING COMPUTER SIMULATIONS FOR EVALUATING THE EFFICACY OF BREAST CANCER CHEMOTHERAPY PROTOCOLS
From MaRDI portal
Publication:4933727
DOI10.1142/S0218202599000312zbMath0933.92022OpenAlexW2104816335MaRDI QIDQ4933727
Dvora Hart, Eliezer Shochat, Zvia Agur
Publication date: 23 January 2000
Published in: Mathematical Models and Methods in Applied Sciences (Search for Journal in Brave)
Full work available at URL: https://doi.org/10.1142/s0218202599000312
Related Items (15)
MODELLING OF THE IMMUNE RESPONSE: CONCEPTUAL FRAMEWORKS AND APPLICATIONS ⋮ Modelling the effects of cell-cycle heterogeneity on the response of a solid tumour to chemotherapy: biological insights from a hybrid multiscale cellular automaton model ⋮ Control strategies for a tumor-immune system with impulsive drug delivery under a random environment ⋮ A mathematical model of combined \textit{bacillus Calmette-Guerin} (BCG) and interleukin (IL)-2 immunotherapy of superficial bladder cancer ⋮ Mathematical model of BCG immunotherapy in superficial bladder cancer ⋮ The modelling of the immune competition by generalized kinetic (Boltzmann) models: Review and research perspectives ⋮ The dynamics of an optimally controlled tumor model: A case study ⋮ Mathematical model of pulsed immunotherapy for superficial bladder cancer ⋮ Integrating cell-cycle progression, drug penetration and energy metabolism to identify improved cancer therapeutic strategies ⋮ Modelling of tumor cells regression in response to chemotherapeutic treatment ⋮ Additional extension of the mathematical model for BCG immunotherapy of bladder cancer and its validation by auxiliary tool ⋮ Dynamic response of cancer under the influence of immunological activity and therapy ⋮ Dynamical analysis of tumor-immune-help T cells system ⋮ Modelling and mathematical problems related to tumor evolution and its interaction with the immune system ⋮ Critical analysis and perspectives on kinetic (cellular) theory of immune competition
Cites Work
This page was built for publication: USING COMPUTER SIMULATIONS FOR EVALUATING THE EFFICACY OF BREAST CANCER CHEMOTHERAPY PROTOCOLS
